Skip to content
Clinical Trials – home
Fondation A De Rothschild
Sponsor

Fondation A De Rothschild

France 29 Rue Manin, 75019 Paris, France

About the sponsor

Clinical research in acute ischemic stroke, ischemic stroke with large core, and subarachnoid hemorrhage includes work on reperfusion, arterial recanalization, and functional recovery. The portfolio also covers cerebral arteriovenous malformations and treatment strategies for patients not eligible for interventional procedures.

  • Endovascular therapy
  • Mechanical thrombectomy
  • Recanalization
  • Functional outcome

These studies reflect a strong interest in acute cerebrovascular care and vascular brain injury.

About Specializations

Fondation A De Rothschild runs clinical trials in conditions such as Ischaemic stroke, Partial seizures, Aneurysm ruptured, Cerebral arteriovenous malformation haemorrhagic, among others.

Recruiting now

Ongoing trials

Clinical trials run by this sponsor – those enrolling participants first.

Condition
Country
City
Type of trial
Recruitment status
Quick filters

12 clinical trials

Countries:FranceFrance
  • Participants:0–17 years · 18–64 years
  • Sponsor:Fondation A De Rothschild
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Dornase Alfa
  • Sponsor:Fondation A De Rothschild
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Bevacizumab
  • Sponsor:Fondation A De Rothschild
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Azathioprine
  • Sponsor:Fondation A De Rothschild
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Ocrelizumab
  • Sponsor:Fondation A De Rothschild
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Tenecteplase
  • Sponsor:Fondation A De Rothschild
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Dexamethasone
  • Sponsor:Fondation A De Rothschild
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Dornase Alfa
  • Sponsor:Fondation A De Rothschild
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Cangrelor Tetrasodium
  • Sponsor:Fondation A De Rothschild

Exudative retinopathy

Not recruiting
Registered drugNo placebo
Countries:FranceFrance
  • Participants:0–17 years
  • Substances:Bevacizumab
  • Sponsor:Fondation A De Rothschild
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Aflibercept
  • Sponsor:Fondation A De Rothschild

Ischaemic stroke

Not recruiting
Registered drug
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Gadobutrol
  • Sponsor:Fondation A De Rothschild

Are you running a clinical trial?

Increase visibility for your trials and help patients find your site through our platform.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.